The metabolism of acetoacetate via a proposed cytosolic pathway in brain of I-week-old rats was investigated. (-)-Hydroxycitrate, an inhibitor of ATP citrate lyase, markedly inhibited the incorporation of carbon from labelled glucose and 3-hydroxybutyrate into cerebral lipids, but had no effect on the incorporation of labelled acetate and acetoacetate into brain lipids. Similarly, n-butylmalonate and benzene-1,2,3-tricarboxylate inhibited the incorporation of labelled 3-hydroxybutyrate but not of acetoacetate into cerebral lipids. These inhibitors had no effect on the oxidation to 14C02 of the labelled substrates used. (-)-Hydroxycitrate decreased the incorporation of3H from 3H20 into cerebral lipids by slices metabolizing either glucose or 3-hydroxybutyrate, but not in the presence of acetoacetate. (-)-Hydroxycitrate also differentially inhibited the incorporation of [2-14C]-leucine and [U-14C]leucine into cerebral lipids. The data show that, although the acetyl moiety of acetyl-CoA generated in brain mitochondria is largely translocated as citrate from these organelles to the cytosol, a cytosolic pathway exists by which acetoacetate is converted directly into acetyl-CoA in this cellular compartment.
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Ketone bodies, 3-hydroxybutyrate and acetoacetate, are excellent fuels for developing rat brain (Itoh & Quastel, 1970; Page et al., 1971; Hawkins et al., 1971) . Since ketone bodies are degraded to acetyl-CoA, they also have the potential to serve as precursors for biosynthesis of lipids , in addition to their role in supplying acetyl-CoA for oxidation in the tricarboxylic acid cycle. A possible role of ketone bodies in the biosynthesis of cerebral lipids by suckling rats (Edmond, 1974; Patel & Owen, 1976) and human foetus has been demonstrated. It is generally accepted that the acetyl moiety of acetyl-CoA formed in the mitochondria is translocated as citrate to regenerate acetyl-CoA for lipogenesis in the cytosol (Spencer & Lowenstein, 1962; Bhaduri & Srere, 1963) . Buckley & Williamson (1973) described the postnatal development ofacetoacetyl-CoA synthetase (acetoacetate-CoA ligase) and acetoacetyl-CoA thiolase (EC 2.3.1.9) in the cytosol ofrat brain. They suggested a cytosolic pathway for direct formation of acetyl-CoA from acetoacetate in the cytosol, in addition to a widely accepted mitochondrial pathway for the incorporation of acetoacetate carbon into brain lipids. The purpose of the present study was to investigate whether a proposed cytosolic pathway for the metabolism of acetoacetate operates in the brain. Vol. 156 A preliminary report of this work has been presented (Patel, 1975 (Majno & Bunker, 1957) . Only the first slice was used and was immediately transferred to a 25ml Erlenmeyer flask containing 3ml of oxygenated high-K+ Krebs- Ringer bicarbonate buffer, pH7.4 (Berl et al., 1968) . The buffer contained labelled substrates and other compounds, as indicated in legends to Tables. The flasks were gassed with 02+CO2 (95:5) and sealed with a rubber serum stopper equipped with a hanging polyethylene centre well, and were placed in a shaking water bath at 37°C for 1 h. At the end ofthe incubation period 0.3 ml of 1 M-Hyamine 10-X was injected into the centre well, and 0.5 ml of 36% (w/v) HCl04 was injected into the medium to stop the reaction and to ensure complete release of CO2. After additional shaking for 40min, the content of the cup was transferred to toluene scintillation fluid (Patel, 1974) , and the radioactivity in 14C02 was counted. The tissue was removed and rinsed three times in water and placed in a tube containing 10ml of chloroform/ methanol (2: 1, v/v) and left overnight. The tissue was then shaken vigorously for 1 min and the extracted lipids were separated into non-saponifiable and fatty acid fractions (Folch et al., 1957) ; the radioactivity in each fraction was determined. For experiments in which 3H20 was used, the chloroform/methanol extracts were washed six to eight times with 5ml of 0.05% CaC12 solution until the aqueous phase became free of contaminating 3H20 radioactivity.
Results and Discussion
It is known that ketone bodies are converted into acetyl-CoA in the mitochondria. This observation is based on the mitochondrial localization of succinylCoA-3-oxo acid CoA-transferase (EC 2.8.3.5) . This enzyme transfers the CoA moiety from succinyl-CoA to acetoacetate, thus forming acetoacetyl-CoA (Green et al., 1953) , which is converted into acetyl-CoA in the mitochondria Itoh & Quastel, 1970) . Buckley & Williamson (1973) postulated a cytosolic pathway by which acetyl-CoA could be directly generated from acetoacetate in the cytosol. Since the inner mitochondrial membrane is impermeable to acetyl-CoA, the acetyl moiety is translocated as citrate into the cytosol, and acetyl-CoA is regenerated by ATP citrate lyase (EC 4.1.3.8) (Spencer & Lowenstein, 1962; Bhaduri & Srere, 1963) . By using the specific inhibitors n-butylmalonate (Robinson & Chappell, 1967) and benzene-1 ,2,3-tricarboxylate (Robinson et al., 1971) for the citrate-transporter system, and (-)-hydroxycitrate for ATP citrate lyase (Watson et al., 1969) , it is possible to inhibit the contribution of the mitochondrial acetyl-CoA pool to the cytosolic acetyl-CoA pool. However, if acetyl-CoA is transported from mitochondria by alternative pathways not involving citrate or is formed by a cytosolic pathway(s), these compounds should not exert inhibitory effects. As seen in Table 1 (Hackenschmidt et al., 1972) . n-Butylmalonate and benzene-1 ,2,3-tricarboxylate, like (-)-hydroxycitrate, diminished the incorporation of 3-hydroxy[3-14C]-butyrate into brain lipids by about 25%, but had no effect on lipid synthesis from [3-14C]acetoacetate. The observed inhibitory effect of benzene-1,2,3-tricarboxylate on the incorporation of [3-14C]acetoacetate into fatty acids but not into non-saponifiable lipids may be attributed to its inhibitory action on acetylCoA carboxylase (Table 1) . It should be noted that both n-butylmalonate and benzene-1,2,3-tricarboxylate had no effect on the oxidation of ketone bodies by brain slices.
By using the incorporation of 3H from 3H20, the rate of total lipid synthesis can be measured independently of the source of acetyl-CoA for lipogenesis (Foster & Katz, 1966; Jungas, 1968) . (-)-Hydroxycitrate inhibited by about 60 or 30% the incorporation of 3H into cerebral lipids by slices metabolizing either glucose or 3-hydroxybutyrate plus glucose respectively (Table 2) . However, this inhibitor again had no effect on lipogenesis from acetoacetate. These results are consistent with findings described in Table 1 in which 14C-labelled substrates instead of 3H20 were used.
The degradation of leucine to acetoacetate and acetyl-CoA is a mitochondrial process (Meister, 1965 (Rous & Favarger, 1973) . The further metabolism of these intermediates of leucine degradation in the presence of (-)-hydroxycitrate was investigated. (-)-Hydroxycitrate had no effect on the oxidation to 14CO2 of either [2-14C]leucine or [U-14C]leucine by brain slices; however, it inhibited the incorporation of carbon atoms from both labelled leucine molecules into cerebral lipids ( Although it is well accepted that citrate is a carrier of the acetyl moiety from the mitochondria to the cytosol in rat liver (Spencer & Lowenstein, 1962; Bhaduri & Srere, 1963) and adipose tissue (Wise & Ball, 1964) , the route(s) by which acteyl-CoA is trans--located in the brain is less certain. In addition to citrate, several other compounds have been suggested to carry out a similar function (D'Adamo & D'Adamo, 1968; D'Adamo & Yatsu, 1966 
